Conferences and fairs support new initiatives for the elderly.

Silver economy promises golden opportunities

13,000 buyers flock to Asia’s premier healthcare and medical sourcing fair.

Summit strives for healthy, inclusive future

The Hong Kong Polytechnic University and Nanjing Hanwei Public Health Research Institute have developed an AI early warning platform to more effectively prevent and treat respiratory infectious diseases.

Hong Kong and Nanjing researchers cooperate to develop early warning platform for respiratory diseases.

AI raises disease alert

Hong Kong is quickly developing into one of the world’s leading innovation hubs, with healthtech and biotech at the forefront.

Hong Kong reforms regulatory approach to fast track drug and medical device development.

Healthtech innovation accelerates

The Hong Kong Polytechnic University has been at the forefront of addressing myopia, an eye disorder that affects one-third of the global population, with a novel non-invasive solution to control the development of myopia in children.

PolyU teams up with leading German lens maker ZEISS to accelerate market penetration of patented myopia control technology.

Farsighted deal to counter myopia

Generating bespoke bone components – anything from a skull plate to part of a load-bearing arm bone – on a 3D printer might seem far-fetched, but that is just what Hong Kong biomaterials pioneer NOVUS Life Sciences does.

A Hong Kong biotech firm established solid overseas connections through HKTDC’s pavilion at a leading German fair.

Bone-builder expands abroad

In the 1970s, Hong Kong was a manufacturing powerhouse churning out everything from toy trains to microchips. Over the 1980s and 90s, the factories migrated north into Mainland China.

Programmes lead the way to bring ‘Made in Hong Kong’ back into the sunshine.

Smart technology revives industry

Hong Kong start-up Neuropix has developed a portable wireless electronic medical device that uses electronic pulses as non-surgical treatment for brain disorders, stimulating cranial nerves and relieving symptoms of cranial nerve diseases.

A Hong Kong entrepreneur is feted for developing a non-invasive electronic-pulse treatment for cranial disorders.

Start-up generates brain waves

The Hong Kong Trade Development Council (HKTDC) helped the Chinese University of Hong Kong (CUHK) reach a research agreement with AI Medical Service (AIM) – a Japanese medical start-up which develops artificial intelligence (AI) endoscopic diagnostic technology – to accelerate development, promote it in Hong Kong and enhance clinical application in other Asian economies.

CUHK and Japanese AI start-up tackle problem of late-diagnosis for alimentary tumours.

AI takes digestive cancers to task

Interest in healthcare and medical developments continues to grow, as economies worldwide recover from the COVID-19 crisis. Market leaders and industry players again congregated at the HKTDC Hong Kong International Medical and Healthcare Fair showcasing medical trends and innovations. Now in its 13th edition, the fair continued to draw an international crowd, including representatives from the Consulates General of Canada, Czech Republic, Israel, and the United States. The physical-online hybrid format, in which the event was conducted, encouraged both on-site and online interactions.

Leading medical industry players reaffirm Hong Kong’s role as a gateway to the massive Mainland China market.

GBA grows into healthcare hub

Hong Kong earlier this month hosted its second Asia Summit on Global Health (ASGH), as the city continues to garner international attention after further loosening COVID-19 restrictions. This year’s theme – “Charting a New Course in Healthcare through Collaboration” resonated strongly with Dr Zsuzsanna Jakab (main picture), Deputy Director-General of the World Health Organization. In her video speech at the event’s opening session, Dr Jakab said the pandemic had infected more than 600 million people globally and claimed 6.5 million lives, so there was an “opportunity and, indeed, an obligation to learn from this pandemic” and accelerate progress on universal healthcare through concerted efforts in science, research, innovation, data and digital technologies.

Diverse range of centres in the Greater Bay Area offer a glimpse into the region’s vibrant healthcare market.

Health summit boosts medical hub credentials

A serial entrepreneur based in Hong Kong for more than 20 years, France-born Sophie Martineau set up her medical supplies business Aquila Healthcare under the brand AquilaVIE in 2020. The launch was in response to the COVID-19 pandemic, when demand for personal protective equipment (PPE) such as masks rapidly outpaced supply.

A medical supply company launched in response to the pandemic found Hong Kong to be the perfect base to grow into a global business.

Healthcare start-up hits a high note

As an international financial centre, Hong Kong is an ideal development base for many overseas enterprises – and the city’s attraction is enhanced by the comprehensive protection its intellectual property laws provide. Some well-known Japanese chain drugstores have chosen to open stores in Hong Kong, and have applied for trademark registration to enhance consumers' recognition of their brands.

Noting the enthusiasm for Japanese goods in Hong Kong, a drugstore moved to the city to meet demand during the pandemic.

IP protection lures Japanese chain

A team from the Chinese University of Hong Kong’s Faculty of Medicine has developed patent technologies that can help pharmaceutical companies improve vaccine effectiveness of their products and efficiency of developing vaccines. The start-up has already signed cooperation agreements with a number of pharmaceutical companies to co-develop vaccines.

Studying the genetic give-and-take between humans and viruses has led to a technology that can greatly accelerate vaccine development.

Decoding viral evolution

Supernova Academy revolutionises medical training through its regional base in Hong Kong.

Medtech start-up leverages city’s innovation ecosystem

Learn about latest market updates and insights to empower your business.

Customise your news by registering online

Subscribe free e-newsletter

Dr Hou Yunlong of Yiling Pharmaceutical talks to the HKTDC at the Asia Summit on Global Health (ASGH). Organised by the Hong Kong Trade Development Council (HKTDC), the fifth ASGH was held on 26-27 May 2025 at the Hong Kong Convention and Exhibition Centre. Under the theme Fostering Global Collaboration for a Shared Future, the summit brings together more than 80 healthcare leaders and experts from around the world to explore the future direction of the industry and collaboration opportunities.

Medicine